Thermo Fisher Scientific Expands Pharma Division in Greenville, North Carolina
03/20/2019
According to company officials the expansion will provide additional capacity for sterile liquid and lyophilized product development and commercial manufacturing.
Included in the site expansion projects are Monza and Ferentino, Italy, and Greenville, North Carolina. In response to customer requests, each of the sites will be equipped with aseptic filling lines and isolator technology. Construction is expected to be completed within the next 24 months.
"These investments will help expand our global sterile manufacturing network and meet the increasing demand from customers that rely on our biologics development and manufacturing expertise," said Michel Lagarde, President of pharma services for Thermo Fisher Scientific.
"We continue to invest to expand our capabilities and help our customers deliver the highest quality medicines to the patients who need them,” Lagarde added.
Most Read
-
-
2020 Gold & Silver Shovel Awards Recognize State and Local Economic Development Efforts
Q2 2020
-
Site Selection 2020: The Importance of “Regional Depth” with Global Reach
Q3 2020
-
2019 Top States for Doing Business: Georgia Ranks #1 Sixth Year in a Row
Q3 2019
-
2019 Leading Metro Locations: Pacific and South-Atlantic Metros Dominate the List
Q4 2019
-
A Heightened Focus on Reshoring
Q3 2020
-
34th Annual Corporate Survey & the 16th Annual Consultants Survey
Q1 2020